March 8, 2022
Life Sciences
  • Bancel also said that Moderna is preparing to launch human trials by 2025 for vaccines targeting 15 viruses and other pathogens that “threaten global health.” He said the $300 million effort seeks to complete early dose and safety testing in case any of the pathogens cause a major epidemic in the future, speeding up the timeline for prototype shots to enter large efficacy trials. (Article here)